 BRIDGEWATER, N.J., Nov. 22, 2022 GLOBE NEWSWIRE -- Hillstream BioPharma, Inc. Nasdaq: HILS Hillstream or the Company, a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug resistant and devastating cancers, will present at the 2022 RHK Capital Disruptive Growth Conference hosted at Reed Smith in New York City on December 5-6, 2022. 